{"entity":{"type":"insider","cik":"0001279901","url":"/insider/0001279901","json_url":"/insider/0001279901.json","name":"CARROLL J MARTIN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":8,"first":"2013-11-27","last":"2023-05-11","span_basis":"filed_date"},"name_variants":[{"name":"CARROLL J MARTIN","source":"filing","n_filings":8,"first_seen":"2013-11-27","last_seen":"2023-05-11"}],"transactions":[{"id":8737329,"accession":"0001628280-23-017563","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-23-017563","line_url":"/filing/0001628280-23-017563#line-2","is_derivative":false,"issuer_cik":"0001279901","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001279901","owner_cik":"0001279901","owner_name":"CARROLL J MARTIN","owner_display_name":"CARROLL J MARTIN","owner_url":"/insider/0001279901","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23091.0,"shares_display":"23,091","price_per_share":1.5714,"price_display":"1.57","price_state":"stated","total_value":36285.1974,"total_display":"36,285.20","total_whole":"36,285","shares_owned_after":36500.0,"shares_owned_after_display":"36,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-11","filed_date":"2023-05-11","scope":"insider"},{"id":8737327,"accession":"0001628280-23-017563","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-017563","line_url":"/filing/0001628280-23-017563#line-1","is_derivative":false,"issuer_cik":"0001279901","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001279901","owner_cik":"0001279901","owner_name":"CARROLL J MARTIN","owner_display_name":"CARROLL J MARTIN","owner_url":"/insider/0001279901","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8409.0,"shares_display":"8,409","price_per_share":1.4919,"price_display":"1.49","price_state":"stated","total_value":12545.3871,"total_display":"12,545.39","total_whole":"12,545","shares_owned_after":13409.0,"shares_owned_after_display":"13,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-10","filed_date":"2023-05-11","scope":"insider"},{"id":6256670,"accession":"0001628280-22-016165","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-016165","line_url":"/filing/0001628280-22-016165#line-1","is_derivative":false,"issuer_cik":"0001279901","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001279901","owner_cik":"0001279901","owner_name":"CARROLL J MARTIN","owner_display_name":"CARROLL J MARTIN","owner_url":"/insider/0001279901","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.6359,"price_display":"5.64","price_state":"stated","total_value":28179.5,"total_display":"28,179.50","total_whole":"28,180","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-03","scope":"insider"},{"id":4978522,"accession":"0000950138-21-000222","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950138-21-000222","line_url":"/filing/0000950138-21-000222","is_derivative":false,"issuer_cik":"0001279901","issuer_name":"Mallinckrodt plc","issuer_ticker":"MNKKQ","issuer_name_source":null,"issuer_url":"/issuer/0001279901","owner_cik":"0001279901","owner_name":"CARROLL J MARTIN","owner_display_name":"CARROLL J MARTIN","owner_url":"/insider/0001279901","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42065.0,"shares_display":"42,065","price_per_share":0.4007,"price_display":"0.40","price_state":"stated","total_value":16855.4455,"total_display":"16,855.45","total_whole":"16,855","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-12","filed_date":"2021-03-16","scope":"insider","n_lines":2},{"id":4354781,"accession":"0000950138-17-000754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950138-17-000754","line_url":"/filing/0000950138-17-000754#line-1","is_derivative":false,"issuer_cik":"0001279901","issuer_name":"Mallinckrodt plc","issuer_ticker":"MNK","issuer_name_source":null,"issuer_url":"/issuer/0001279901","owner_cik":"0001279901","owner_name":"CARROLL J MARTIN","owner_display_name":"CARROLL J MARTIN","owner_url":"/insider/0001279901","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":20.4187,"price_display":"20.42","price_state":"stated","total_value":102093.5,"total_display":"102,093.50","total_whole":"102,094","shares_owned_after":23423.0,"shares_owned_after_display":"23,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-09","filed_date":"2017-11-13","scope":"insider"},{"id":2068791,"accession":"0000899243-16-020238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-020238","line_url":"/filing/0000899243-16-020238#line-1","is_derivative":false,"issuer_cik":"0001279901","issuer_name":"INOTEK PHARMACEUTICALS CORP","issuer_ticker":"ITEK","issuer_name_source":null,"issuer_url":"/issuer/0001279901","owner_cik":"0001279901","owner_name":"CARROLL J MARTIN","owner_display_name":"CARROLL J MARTIN","owner_url":"/insider/0001279901","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.0294,"price_display":"9.03","price_state":"stated","total_value":90294.0,"total_display":"90,294.00","total_whole":"90,294","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-13","filed_date":"2016-05-17","scope":"insider"},{"id":8705009,"accession":"0001387131-15-001611","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-15-001611","line_url":"/filing/0001387131-15-001611#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001279901","owner_name":"CARROLL J MARTIN","owner_display_name":"CARROLL J MARTIN","owner_url":"/insider/0001279901","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.11,"price_display":"6.11","price_state":"stated","total_value":61100.0,"total_display":"61,100.00","total_whole":"61,100","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-08","filed_date":"2015-05-12","scope":"insider"},{"id":6801314,"accession":"0001445064-14-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001445064-14-000028","line_url":"/filing/0001445064-14-000028#line-1","is_derivative":false,"issuer_cik":"0001279901","issuer_name":"Mallinckrodt plc","issuer_ticker":"MNK","issuer_name_source":null,"issuer_url":"/issuer/0001279901","owner_cik":"0001279901","owner_name":"CARROLL J MARTIN","owner_display_name":"CARROLL J MARTIN","owner_url":"/insider/0001279901","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":69.24,"price_display":"69.24","price_state":"stated","total_value":138480.0,"total_display":"138,480.00","total_whole":"138,480","shares_owned_after":9209.0,"shares_owned_after_display":"9,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-12","scope":"insider"},{"id":4796051,"accession":"0001225208-13-024372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-13-024372","line_url":"/filing/0001225208-13-024372#line-1","is_derivative":false,"issuer_cik":"0001279901","issuer_name":"Mallinckrodt plc","issuer_ticker":"MNK","issuer_name_source":null,"issuer_url":"/issuer/0001279901","owner_cik":"0001279901","owner_name":"CARROLL J MARTIN","owner_display_name":"CARROLL J MARTIN","owner_url":"/insider/0001279901","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":51.27,"price_display":"51.27","price_state":"stated","total_value":102540.0,"total_display":"102,540.00","total_whole":"102,540","shares_owned_after":5034.0,"shares_owned_after_display":"5,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-26","filed_date":"2013-11-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434868","name":"Esperion Therapeutics, Inc.","url":"/issuer/0001434868","role":"Director","n_filings":2,"first_seen":"2022-06-03","last_seen":"2023-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001567892","name":"Mallinckrodt plc","url":"/issuer/0001567892","role":"Director","n_filings":4,"first_seen":"2013-11-27","last_seen":"2021-03-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001281895","name":"INOTEK PHARMACEUTICALS CORP","url":"/issuer/0001281895","role":"Director","n_filings":1,"first_seen":"2016-05-17","last_seen":"2016-05-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000025743","name":"TherapeuticsMD, Inc.","url":"/issuer/0000025743","role":"Director","n_filings":1,"first_seen":"2015-05-12","last_seen":"2015-05-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001279901","retrieved_at":"2026-08-22T09:55:34+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}